HIV/AIDS News

Artificial intelligence has emerged as a potentially important tool for patient care, including in infectious diseases.

The U.S. House of Representatives reauthorized the U.S. President’s Emergency Plan for AIDS Relief for 1 year as part of a spending package passed on Friday, sending the plan to the Senate for consideration.

Use of an electronic health record-based intervention significantly increased PrEP use among patients of primary care physicians who care for people with HIV, a randomized trial found.

DENVER — A national HIV self-testing program found high demand for tests, with many participants testing for the first time, according to a study.

DENVER — Long-acting ART was shown to be safe and effective in a study conducted in sub-Saharan Africa — an “essential first step” in demonstrating its potential use to treat HIV on the continent, an expert said.

DENVER — Among people with HIV, hybrid immunity against COVID-19 is more effective at preventing infection and severe disease than vaccination alone, according to a study.

DENVER — People with HIV who have challenges adhering to a daily oral regimen should be offered long-acting formulations of ART, study findings suggest.

DENVER — HIV infections linked to “vampire facials” performed at a spa in New Mexico could have been avoided if the now-closed spa had adhered to appropriate infection prevention and control practices, experts said.

DENVER — Four children born with HIV who initiated ART within 48 hours of delivery later remained in treatment-free remission for over a year after ART was paused, researchers reported.

DENVER — A low weekly dose of semaglutide can safely minimize what used to be called nonalcoholic fatty liver disease in people with HIV, a first-of-its-kind study found.